STOCK TITAN

Sale of 10,411 ordinary shares planned by issuer (NASDAQ: WVE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder has filed a Rule 144 notice to sell 10,411 ordinary shares. The shares are planned to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC at an aggregate market value of $140,027.95, with 187,693,059 shares outstanding.

The securities to be sold were acquired on 02/08/2026 through the vesting of restricted stock units as equity compensation from the issuer, with payment also dated 02/08/2026. The notice includes a representation that the seller is not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Rule 144 filing for WVE disclose about planned share sales?

The Rule 144 filing discloses a planned sale of 10,411 ordinary shares on NASDAQ. The shares are associated with issuer WVE and will be sold through Morgan Stanley Smith Barney LLC, reflecting a routine resale of previously acquired equity compensation.

How many WVE ordinary shares are planned to be sold and at what market value?

The notice covers 10,411 ordinary shares with an aggregate market value of $140,027.95. This value is based on market pricing at the time of the filing and indicates the approximate dollar size of the planned transaction for the selling holder.

How were the WVE shares in this Rule 144 notice acquired by the seller?

The 10,411 ordinary shares were acquired through restricted stock unit vesting on 02/08/2026. The acquisition is classified as equity compensation from the issuer, with the same date recorded for both the vesting event and the related equity payment.

On which exchange will the WVE shares in this Rule 144 filing be sold?

The ordinary shares referenced in the Rule 144 filing are planned to be sold on the NASDAQ exchange. The broker handling the transaction is Morgan Stanley Smith Barney LLC, operating from its Executive Financial Services office in New York.

What does the filer represent about undisclosed information in the WVE Rule 144 notice?

The filer represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is part of the signature section and aligns with Rule 144 and related securities law requirements.
Wave Life Scienc

NASDAQ:WVE

View WVE Stock Overview

WVE Rankings

WVE Latest News

WVE Latest SEC Filings

WVE Stock Data

1.25B
161.41M
Biotechnology
Pharmaceutical Preparations
Link
Singapore
SINGAPORE